Background and aim: Erectile dysfunction (ED) can be present in diabetic patients not only induced by androgen deficiency, but also as a consequence of diabetes chronic complications. The aim of our study was to evaluate androgen status and chronic microvascular complications in patients with diabetes mellitus (DM), with and without ED. Material and methods: 292 patients (44 Type 1 diabetes - T1DM/ 248 Type 2 diabetes - T2DM), were evaluated for androgen status: dehydroepiandrosterone (DHEA), free testosterone (FT) and presence of chronic complications. ED was diagnosed by a score under 22 of 5-item International Index of Erectile Function (IIEF). Patients with free-testosterone < 70 pg/ml were considered hypogonadal. Results: Prevalence of ED was higher in T2DM 87.5% than in T1DM 65.9%. In patients with ED the prevalence of hypogonadism was 31.3% in T1DM, 26.7% in T2DM. In older T2DM patients IIEF-score was significantly correlated with DHEA. There was a significant correlation between ED and retinopathy in T1DM, additionally with neuropathy in T2DM. Conclusions: ED is a common comorbidity in diabetic patients, associated with other microvascular complications. Hypogonadal status might explain up to 30% of ED. In older diabetic men, severity of ED is related to lower DHEA.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RG, MC Kinley JB. Impotence and its medical and psychosocial relates: results of the Massachusetts Male Ageing Study. J Urol 151: 54-61, 1994.
2. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in man. Clin Endocrinol (Oxf) 63: 239-250, 2005.
3. Kempler P. Erectile dysfunction. In: Neuropathies. Kempler P (ed). Springer Scientific Publisher, Budapest, pp. 123-128, 2002.
4. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metabol 89: 5462-5468, 2004.
5. Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176: 1524-1528, 2006.
6. Haffner SM, Shaten J, Stern MP et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 143: 889-897, 1996.
7. Stellato RK, Feldman HA, Hamdy O, Horton ES, Mc Kinlay JB. Testosterone, sex hormone-binding globulin and the development of type 2 diabetes in middleaged men: prospective results from the Massachusetts male ageing study. Diabetes Care 23: 490-494, 2000.
8. Laaksonen D, Niskanen L, Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle age men. Diabetes Care 27: 1036-1041, 2004.
8. Laaksonen D, Niskanen L, Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle age men. Diabetes Care 27: 1036-1041, 2004.10.2337/diacare.27.5.1036)| false
9. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5- item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11: 319-326, 1999.